Japan is out of favour, especially with foreign investors, and the market has sold down amid rising global macroeconomic concerns and volatility in returns. In particular, investors have shunned stocks where earnings are perceived to be cyclical or volatile in the shorter term.
But within the Japanese market, rising risk aversion is driving valuations to both extremes of expensive and cheap. A contrarian focus on the most mispriced Japanese stocks offers significant opportunities for the patient. On the one hand, the market's risk aversion is driving a strong preference for expensively valued defensive stocks, such as consumer staples, pharmaceuticals and rail companies. Defensive stocks are more expensively valued than any time in the past 20 years. Investors should start by focusing on the extremes of cheap valuation where there are plenty of opportuniti...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes